Post by GSK

Name: #News for #investors and #media: Today we announced that our investigational liver therapy received
Uploaded: 2026-04-27T11:05:27.455Z
Channel: GSK
Description: #News for #investors and #media: Today we announced that our investigational liver therapy received US FDA Breakthrough Therapy and EMA Priority Medicine (PRIME) regulatory designations for metabolic

4,798,407 followers

#News for #investors and #media: Today we announced that our investigational liver therapy received US FDA Breakthrough Therapy and EMA Priority Medicine (PRIME) regulatory designations for metabolic dysfunction-associated steatohepatitis (MASH). Find out more: https://gsk.to/3QMo7Fo

Video Content